Drug Discovery

Science 37 Stock for Decentralized Clinical Trials

Nothing like a pandemic to illuminate a thing or two about human nature. For example, people apparently spend way too much time wiping their butts. Or, at the very least, are very inefficient in their use of toilet paper. We also learned quite a bit about clinical trials, though the COVID-19 vaccine studies were atypical […]

How Eikon Uses Fluorescence Microscopy for Drug Discovery

Back in the 1670s, a Dutch cloth merchant by the name of Antonie van Leeuwenhoek invented the first microscopic lens to get a better view of his cloth threads. Using his new invention, he discovered the microscopic world of cells, bacteria, and oddly enough, sperm. He singlehandedly became the father of microbiology. While it’s a […]

AbCellera Stock – Turning Antibodies Into Drugs

We believe it’s critically important to only invest in businesses that we understand. If you need a subject matter expert to explain a company’s value proposition, you shouldn’t be invested in it. Yesterday’s article on A Pure-Play LegalTech Stock for FinTech Investors is a great example of a value proposition that’s easy to understand. Today, […]

7 Companies Using AI for Drug Discovery

Drug development is complicated business. Medicinal chemists, many who have spent nearly a decade training in the halls of academia, are tasked with painstakingly synthesizing each and every molecule that could potentially have a therapeutic effect. These compounds need to then be screened in cells just to make sure they’re not just straight-up toxic, with […]

Recursion Stock – Revolutionizing Drug Discovery With AI

Technological advancement makes people uncomfortable, and artificial intelligence (AI) is no exception. It’s going to uncover things we don’t like, things we cannot explain, and things that truly impact mankind – maybe even all at the same time. How it can possibly add so much value may remain a mystery at times. For us to […]

Company Uses AI Drug Discovery for Designing Biologics

The bright minds at Insilico Medicine announced just today a major breakthrough in the rapidly growing field of AI drug discovery. The Hong Kong startup used a type of AI system called deep learning to simultaneously identify both a small-molecule drug and its ideal biological target to treat pulmonary fibrosis. It took just 18 months […]

What Happened to 3D-Printed Drugs?

Healthcare is usually seen as pretty recession proof. After all, when things head south, our health can go sideways. But the current pandemic has reportedly wiped out 1.4 million jobs in the medical field. (Do you really want to go in for that nose job and leave with a potentially deadly pulmonary infection?) While the […]

The Lantern Pharma IPO Raises Some Questions

We recently published a report on seven AI healthcare stocks noting that six were the result of recent IPOs. Of those, two are involved in drug discovery. We’ve written extensively about how machine learning and computational chemistry are speeding up the drug development process and decreasing the likelihood that drugs will fail. It’s all about […]

A Computational Chemistry IPO From Schrodinger

Elon Musk once said that there’s a one in a billion chance we’re not living in a simulation. Sounds far-fetched until you start digging into simulation theory a bit. It’s backed by theories from leading academics, like Nick Bostrom’s “simulation argument,” which presents three likelihoods, each equally frightening to ponder. To paraphrase Arthur C. Clarke, it is […]